造血干细胞移植

zào xuè ɡān xì bāo yí zhí
  • hematopoietic stem cell transplantation;hemopoietic stem cell transplantation
造血干细胞移植造血干细胞移植
  1. 目的评价自体造血干细胞移植(AHSCT)治疗恶性血液病的疗效。

    Objective To evaluate the clinical outcome of autologous hemopoietic stem cell transplantation ( AHSCT ) for hematological malignancies .

  2. 超声对造血干细胞移植后肝静脉闭塞症的诊断价值

    Diagnostic value of abdominal ultrasonogram in hemopoietic stem cell transplantation patients with hepatic veno-occlusive disease

  3. 2例B细胞非霍奇金淋巴瘤患者异基因造血干细胞移植联合利妥昔单抗治疗的护理

    Nursing Care for Patients with B-Cell Non-Hodgkin 's Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation Combined with Rituximab

  4. 自体外周造血干细胞移植后对多发性硬化患者MRI强化病灶的影响

    Autologous peripheral blood stem cell transplantation suppresses Gd-enhanced MRI activity in progressive multiple sclerosis

  5. DNA多态性分析技术检测异基因造血干细胞移植后植活的证据

    Study on DNA Polymorphism Analysis Technique as an Evidence of Engraftment Status after Allogeneic Hematopoietic Stem Cell Transplantation

  6. 造血干细胞移植后巨细胞病毒感染患者糖蛋白B基因分型的初步研究

    A study of cytomegalovirus ( CMV ) glycoprotein B genotypes in patients with CMV infection after hematopoietic stem cell transplantation

  7. MM的治疗主要包括传统化疗,造血干细胞移植以及新药治疗。

    The treatments of MM include conventional chemotherapy , hematopoietic stem cell transplantation and new drugs .

  8. 脐血造血干细胞移植的产前HLA配型研究

    Study on prenatal HLA typing for transplantation of umbilical cord-blood stem cells

  9. 结论FISH可能成为白血病造血干细胞移植后疗效观察和微小残留病定量监测的重要手段。

    Conclusion FISH is likely an important tool for monitoring treatment and revealing minimal residual disease in CML after HSCT .

  10. NK细胞在异基因造血干细胞移植中对移植物抗白血病效应及移植物抗宿主病作用的影响

    Effects of NK cells on the GVHD and GVL in Allo-HSCT

  11. 方法利用ELISA和PCR方法对30例异基因造血干细胞移植受者进行检测。

    Methods 30 patients undergoing allogeneic hematopoietic stem cell transplantation were detected by using ELISA and PCR .

  12. 非血缘及HLA配型不合造血干细胞移植的临床研究

    Treatment of leukemia by unrelated donor or HLA mismatched hematopoietic stem cell transplantation

  13. HLA配型不合造血干细胞移植术后免疫功能重建及其与发生感染的关系

    Clinical study on immune reconstitution and infection after HLA-mismatched hematopoietic stem cell transplantation

  14. HLA配型不合情况下造血干细胞移植的新方法

    A novel approach to HLA - mismatched transplantation

  15. 急性白血病患者HLA不全相合非清髓造血干细胞移植后淋巴细胞亚群变化分析

    Changes of Lymphocyte Subsets in Acute Leukemia Patients after HLA-mismatched Nonmyeloablative Hematopoietic Stem Cell Transplantation

  16. HLA单倍相合造血干细胞移植治疗恶性血液病的临床研究

    Clinical study on haploid HLA-haploidentical hematopoietic stem cell transplantation for treatment of malignant hematological disease

  17. 用基于SNP分型的实时PCR定量检测造血干细胞移植后的嵌合体

    Quantitative Analysis of Chimerism after Hematopoietic Stem Cell Transplantation by Real-Time PCR Using SNP-based Genotyping

  18. 结论FLAG方案治疗难治复发AL疗效显著,为患者进行造血干细胞移植赢得了时机。

    Conclusion FLAG shows obvious efficts for refractory and relapsing acute leukemia and gains time for hematopoietic stem cell transplantation .

  19. 白血病异基因造血干细胞移植后TCRVβ亚家族基因谱的研究

    Study on TCR V β subfamily genes following allogeneic hematopoietic stem cell transplantation in leukemic patients

  20. 目的总结异基因造血干细胞移植后中毒性表皮松解症(TEN)诊治经验。

    Objective To conclude the experiences of the diagnosis and treatment of toxic epidermal necrolysis ( TEN ) after allogenic peripheral blood stem cell transplantation .

  21. 目的探讨HLA不完全相合的造血干细胞移植治疗白血病的新方法。

    Objective : To investigate the new method of HLA mismatched allogenic stem cell transplantation for leukemia .

  22. HLA相合同胞供者异基因造血干细胞移植治疗慢性粒细胞白血病40例

    HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia in 40 cases

  23. ABO主血型不合的非清髓性异基因造血干细胞移植2例

    Major ABO - incompatible allogeneic non-myeloablative hematopoietic stem cell transplantation

  24. 尽管有多种化疗联合方案及造血干细胞移植的应用,MM仍然是一种预后较差的疾病。

    Although a variety of chemotherapy regimens and the application of hematopoietic stem cell transplantation , multiple myeloma remains a disease of poor prognosis .

  25. 该文综述了MM的化学治疗、造血干细胞移植、生物治疗、支持治疗及免疫治疗现状及其进展。

    This article reviews current situation and recent advances about chemotherapy , hemopoietic stem cell transplant , biotherapy , supportive treatment and immunotherapy of MM .

  26. HLA相合同胞异基因造血干细胞移植治疗慢性粒细胞白血病第1次慢性期51例分析

    HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase . Analysis of 51 cases

  27. 不完全相合造血干细胞移植中GVHD的预测研究:模拟HLA抗原结构的比较与应用

    The application of molecular modeling of HLA antigens in unmatched stem cell transplantation for GVHD prediction

  28. 尤其患者在异基因造血干细胞移植(allogeneichaematopoieticstemcelltransplantation,allo-HSCT)术后,HCMV激活是一种常见的并发症。

    Especially in patients undergoing allogeneic haematopoietic stem cell transplantation ( allo-HSCT ), HCMV reactivation is a frequent complication .

  29. 自身免疫病患者造血干细胞移植后Ts及Tc细胞的变化

    Alteration of Ts and Tc lymphocytes subsets in patients with serious autoimmune disease after autologous hematopoietic stem cell transplantation

  30. 受体MHC抗原诱导供体胚胎期免疫耐受应用于造血干细胞移植的研究

    Recipient MHC Antigen Induces Donor Immunotolerance in Embryonic Stage to Used in Hematopoietic Stem Cell Transplantation